(Q35991934)

English

Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

0 references

Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Setor K Kunutsor

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

S Seidu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

K Khunti

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

publication date

22 May 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Diabetic Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

316-327

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Is diabetes a coronary risk equivalent? Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

The platelet in diabetes: focus on prevention of ischemic events

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Antiplatelet therapy for every diabetic person?

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Aspirin for primary prevention of cardiovascular events in people with diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Aspirin resistance and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Approaches to prevention of cardiovascular complications and events in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Low-dose aspirin for the prevention of atherothrombosis

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

1 reference

https://api.crossref.org/works/10.1111%2FDME.13133

21 January 2018

Identifiers

10.1111/DME.13133

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086572%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35991934&oldid=1644835521"